Home

Lyka Labs Ltd PE Ratio

Image

Lyka Labs Ltd

NSE: LYKALABS

PE

175

Last updated on: Jan 15, 2025

Key Highlights

  • The P/E Ratio of Lyka Labs Ltd is 175 as of 15 Jan 15:30 PM .
  • The P/E Ratio of Lyka Labs Ltd changed from 10 on March 2022 to 0 on March 2024 . This represents a CAGR of -100.00% over 3 years.
  • The Latest Trading Price of Lyka Labs Ltd is ₹ 152.65 as of 15 Jan 16:01 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 40.0 in 5 years. This represents a CAGR of 13.75%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.4. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 36.9 in 2024.

Historical P/E Ratio of Lyka Labs Ltd

No data available

Company Fundamentals for Lyka Labs Ltd

Image

Lyka Labs Ltd

NSE: LYKALABS

Share Price

₹ 152.65

-3.10 (-1.99%)

stock direction

Last updated on: Jan 15, 2025

Market Price of Lyka Labs Ltd

1M

1Y

3Y

5Y

Monitoring Lyka Labs Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
14 Jan 2025155.75
13 Jan 2025153.5
10 Jan 2025149.8
09 Jan 2025148.45
08 Jan 2025157.85
07 Jan 2025159.45
06 Jan 2025159.15
03 Jan 2025163.2
02 Jan 2025161.8
01 Jan 2025156.5

SWOT Analysis Of Lyka Labs Ltd

Strength

1

che

Weakness

4

che

Opportunity

1

che

Threats

1

che

BlinkX Score for Lyka Labs Ltd

Asset Value vs Market Value of Lyka Labs Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Lyka Labs Ltd555.87
Sun Pharmaceuticals Industries Ltd424382
Divis Laboratories Ltd159224
Cipla Ltd116943
Dr Reddys Laboratories Ltd111588

PE Ratio of Lyka Labs Ltd Explained

``

555.87

Market cap

3

Earnings

175.0X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Lyka Labs Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Lyka Labs Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Lyka Labs Ltd

No data available

* All values are in %

About Lyka Labs Ltd

  • Initially manufacturing formulations, Lyka Labs Limited brought bulk drugs into its operational fold by amalgamating Lyphin Chemicals Pvt Ltd with itself in Apr. '83.
  • It also added a range of ayurvedic and animal health care products over the years.
  • In 1990, it diversified into marketing medical and diagnostic equipment and instruments of Bekton Dickinson, US; Airsep Corporation, US; Coloplast, Denmark; and Terumo Corporation, Japan.
  • Lyka Exports is the subsidiary of the company.
  • The Company is engaged in the business of pharmaceutical and related activities, including research. The company offers a broad range of antibiotics used as life-savers and to treat minor infections.

Lyka Labs Ltd News Hub

Lyka Labs reports consolidated net profit of Rs 1.44 crore in the June 2024 quarter

Net profit of Lyka Labs reported to Rs 1.44 crore in the quarter ended June 2024 as against net loss

Read more

2024-08-09 00:00:00

Lyka Labs to hold board meeting

Lyka Labs will hold a meeting of the Board of Directors of the Company on 9 August 2024. Powered by

Read more

2024-08-02 00:00:00

Lyka Labs to hold board meeting

Lyka Labs will hold a meeting of the Board of Directors of the Company on 11 October 2024 Powered by

Read more

2024-10-04 00:00:00

Lyka Labs announces board meeting date

Lyka Labs will hold a meeting of the Board of Directors of the Company on 12 November 2024. Powered

Read more

2024-10-23 00:00:00

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Lyka Labs Ltd

What is the current PE Ratio of Lyka Labs Ltd?

The Current PE Ratio of Lyka Labs Ltd is 175.0 as on 15 Jan 2025.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 15 Jan 2025.

What was the PE Ratio of Lyka Labs Ltd last year?

The PE Ratio of Lyka Labs Ltd was 0.0 last year, now the PE ratio is 175.0, showing a year-on-year growth of -%.

What does the PE Ratio of Lyka Labs Ltd indicate about its stock?

The PE Ratio of Lyka Labs Ltd is 175.0. This ratio indicates that investors are willing to pay 175.0 times the earnings per share for each share of Lyka Labs Ltd.

What is the PE Ratio Growth of Lyka Labs Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Lyka Labs Ltd grew by -% whereas, the EPS ratio grew by 45.0.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions